{"nct_id":"NCT03333317","title":"A Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Infants and Children Aged 28 Days to 36 Months Infected With Respiratory Syncytial Virus","status":"TERMINATED","status_verified_date":"2019-12","start_date":"2017-11-24","start_date_type":"ACTUAL","primary_completion_date":"2018-03-23","primary_completion_date_type":"ACTUAL","completion_date":"2018-03-23","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}